TP53 and colorectal carcinoma: By contrast, HCT116 is a transformed colorectal carcinoma cell line, for which an otherwise isogenic but p53-negative counterpart has been generated by gene targeting (Fig. 1B), enabling the role of p53 in the response to be determined.